“Nushama is a medically supervised psychedelic wellness center that provides intravenous (IV) ketamine for an ego-dissolving psychedelic experience. The center says Ketamine Psychedelic Therapy (KPT) can provide sustained relief from depression, anxiety, chronic pain, addiction and trauma-induced mood disorders.” | learn more
“Early reports from Small Pharma suggest that DMT, in conjunction with therapy, can be used to help break away from undesired behavioral patterns. Other studies also suggest that it could prove useful in helping with depression and anxiety.” | learn more
“The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression measure revealing no significant difference between the two treatments, but a number of secondary measures notably favoring psilocybin.” | learn more
While I’m not in the market for middle school textbooks, I am fond of this one for its approach. Ever since Hans Rosling helped me realize my world view was based on decades-old and outdated data, I’ve wondered if that cycle persists. […]
“Australian scientists have developed a world-first test claimed to accurately measure levels of a brain protein associated with depression and bipolar disorder. The test could offer doctors an objective diagnostic tool to assess patients.” | learn more
“Esketamine represents the first depression drug in years to be approved that works via a completely different mechanism in the brain, as compared to the previous generation of medications. For many with treatment-resistant depression, the new drug offers newfound hope […]
A new study “provides clear evidence that some kinds of epigenetic markers can be passed on to a new generation.” This lends some credibility to a 2015 study “claiming that the children of Holocaust survivors were more likely to develop […]